Data as of Apr 16
| +0.84 / +2.74%|
The 4 analysts offering 12-month price forecasts for Medifast Inc have a median target of 32.50, with a high estimate of 37.00 and a low estimate of 27.00. The median estimate represents a +3.11% increase from the last price of 31.52.
The current consensus among 4 polled investment analysts is to Buy stock in Medifast Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.